Danaher shares rise in premarket trade as Q3 earnings beat estimates

Investing.com – Danaher Corporation (NYSE: DHR) shares rose in premarket trading on Wednesday after the life sciences and diagnostics company reported third-quarter adjusted earnings of $2.11 per share, beating analyst expectations of $1.92, while revenue climbed 8.5% year on year to $6.6 billion, topping estimates of $6.56 billion.

The company raised its full-year 2026 adjusted diluted earnings per share guidance to a range of $8.57 to $8.62, up from previous guidance of $8.45 to $8.60. The midpoint of $8.60 exceeds the analyst consensus of $8.51.

"We delivered better-than-expected third quarter revenue, earnings and cash flow, and are encouraged by the improving trends we saw across our end markets," said Julie Sawyer Montgomery, President and Chief Executive Officer.

"The continued acceleration in core revenue growth excluding respiratory revenue, together with DBS-driven execution drove double-digit adjusted EPS growth and underscored our ability to convert improving demand into strong financial performance."

For the fourth quarter, Danaher anticipates non-GAAP core revenue excluding respiratory revenue will increase in the 4.0% to 5.0% range. The company expects respiratory revenue to be an approximately 150 basis point headwind, resulting in core revenue growth of approximately 3.0%.

Net earnings for the quarter were $1.2 billion, or $1.71 per diluted share, up 34.5% YoY. Operating cash flow reached $1.9 billion while non-GAAP free cash flow totaled $1.6 billion. Non-GAAP core revenue excluding respiratory revenue increased 5.5% YoY, while non-GAAP core revenue increased 3.0% YoY.

Original Article

You May Also Be Interested In

• Tesla stock up as automotive gross margin improves, free cash flow turns positive
• Oceaneering (OII) Misses Q3 EPS by 9c
• Danaher Reports Third Quarter 2026 Results